21.84
Healthpeak Properties Inc stock is traded at $21.84, with a volume of 2.85M.
It is down -1.02% in the last 24 hours and up +2.03% over the past month.
Healthpeak owns a diversified healthcare portfolio of approximately 700 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.
See More
Previous Close:
$22.06
Open:
$22.07
24h Volume:
2.85M
Relative Volume:
0.35
Market Cap:
$15.05B
Revenue:
$2.87B
Net Income/Loss:
$250.10M
P/E Ratio:
68.49
EPS:
0.3188
Net Cash Flow:
$1.13B
1W Performance:
-1.95%
1M Performance:
+2.03%
6M Performance:
+26.65%
1Y Performance:
+28.90%
Healthpeak Properties Inc Stock (DOC) Company Profile
Name
Healthpeak Properties Inc
Sector
Industry
Phone
949-407-0700
Address
4600 SOUTH SYRACUSE STREET, DENVER, WI
Compare DOC vs WELL, VTR, OHI, AHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DOC
Healthpeak Properties Inc
|
21.83 | 15.53B | 2.87B | 250.10M | 1.13B | 0.3188 |
|
WELL
Welltower Inc
|
234.86 | 175.31B | 11.75B | 1.46B | 2.19B | -0.6014 |
|
VTR
Ventas Inc
|
93.58 | 48.67B | 6.13B | 272.21M | 1.38B | 0.5521 |
|
OHI
Omega Healthcare Investors Inc
|
50.65 | 15.31B | 1.24B | 655.98M | 857.80M | 2.063 |
|
AHR
American Healthcare Reit Inc
|
55.62 | 11.07B | 2.37B | 101.67M | 169.19M | 0.5775 |
Healthpeak Properties Inc Stock (DOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-20-26 | Initiated | UBS | Neutral |
| Feb-05-26 | Downgrade | Argus | Buy → Hold |
| Jan-09-26 | Initiated | Goldman | Neutral |
| Dec-16-25 | Downgrade | Jefferies | Buy → Hold |
| Oct-01-25 | Initiated | Cantor Fitzgerald | Neutral |
| Sep-15-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-20-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-29-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Jan-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-21-24 | Upgrade | Deutsche Bank | Hold → Buy |
| May-03-24 | Upgrade | Wedbush | Neutral → Outperform |
| Apr-26-24 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Apr-22-24 | Resumed | Mizuho | Buy |
| Apr-01-24 | Upgrade | BofA Securities | Underperform → Buy |
| Mar-25-24 | Resumed | Wells Fargo | Equal Weight |
| Mar-08-24 | Resumed | RBC Capital Mkts | Outperform |
| Jan-05-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-26-23 | Initiated | JMP Securities | Mkt Outperform |
| Apr-20-23 | Initiated | Wells Fargo | Underweight |
| Dec-14-22 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Oct-28-22 | Initiated | JP Morgan | Neutral |
| Aug-05-22 | Downgrade | Colliers Securities | Buy → Neutral |
| Jun-03-22 | Initiated | CapitalOne | Equal Weight |
| May-19-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Apr-26-22 | Initiated | Barclays | Overweight |
| Feb-01-22 | Initiated | Credit Suisse | Neutral |
| Jan-07-22 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-13-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-20-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-14-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-15-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-13-21 | Upgrade | Jefferies | Hold → Buy |
| Dec-14-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-11-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-30-20 | Resumed | Robert W. Baird | Outperform |
| Sep-02-20 | Resumed | Stifel | Buy |
| Apr-07-20 | Downgrade | Citigroup | Buy → Neutral |
| Apr-01-20 | Upgrade | Berenberg | Hold → Buy |
| Mar-16-20 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-09-20 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Feb-27-20 | Upgrade | CapitalOne | Equal Weight → Overweight |
| Dec-20-19 | Initiated | Mizuho | Buy |
| Dec-12-19 | Upgrade | Citigroup | Neutral → Buy |
| Nov-26-19 | Upgrade | Stifel | Hold → Buy |
| Oct-14-19 | Initiated | BofA/Merrill | Neutral |
| Jun-20-19 | Initiated | Citigroup | Neutral |
| May-02-19 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Aug-03-18 | Upgrade | CapitalOne | Equal Weight → Overweight |
| Apr-25-18 | Downgrade | Stifel | Buy → Hold |
| Mar-01-18 | Reiterated | B. Riley FBR, Inc. | Buy |
| Jan-05-18 | Reiterated | Robert W. Baird | Outperform |
| Nov-06-17 | Upgrade | Hilliard Lyons | Long-term Buy → Buy |
View All
Healthpeak Properties Inc Stock (DOC) Latest News
Healthpeak Properties Inc. stock outperforms competitors on strong trading day - MarketWatch
BMO Capital Adjusts Price Target on Healthpeak Properties to $25 From $24, Maintains Outperform Rating - marketscreener.com
Healthpeak Properties, Inc. Revenue Breakdown – BMV:DOC - TradingView
Healthpeak Properties (DOC) Rebound Puts Its Fair Value Debate Back In Focus - simplywall.st
PEAK5302933 Bond Profile — Key Metrics - TradingView
PEAK5302933 Bond Risk Profile - TradingView
HCP Changes Name to Healthpeak Properties - Nareit
Healthpeak Properties (NYSE:DOC) Faces A Valuation Split - Kalkine Media
Analysts Conflicted on These Real Estate Names: Healthpeak Properties (DOC) and Blackstone Mortgage (BXMT) - The Globe and Mail
Healthpeak Properties Inc. stock outperforms competitors despite losses on the day - MarketWatch
JPMorgan Chase (NYSE: JPM) discloses 4.3% beneficial stake in Healthpeak Properties - Stock Titan
Latham & Watkins Represents Healthpeak Properties in a US$2.1 Billion Strategic Joint Venture With Brookfield Asset Management - Legal Desire Media and Insights
Latham Watkins Represents Healthpeak Properties in a Strategic Joint Venture With Brookfield - Latham & Watkins LLP
PEAK5214875 Bond Risk Profile - TradingView
Evercore ISI Adjusts Price Target on Healthpeak Properties to $23 From $21, Maintains In Line Rating - Moomoo
Brookfield picks up stake in Healthpeak’s $2B medical office venture - The Real Deal
Brookfield Asset Management (TSX:BAM) Partners With Healthpeak On $2.1 Billion Medical Buildings Venture - Yahoo Finance
Healthpeak & Brookfield Form Outpatient Medical Joint Venture - Yahoo Finance
JPMorgan Adjusts Price Target on Healthpeak Properties to $22 From $21, Maintains Neutral Rating - marketscreener.com
Healthpeak, Brookfield form $2.1bn outpatient medical joint venture - Alternatives Watch
Healthpeak Properties (DOC) Secures $1.025B from Joint Venture w - GuruFocus
Barclays Maintains Healthpeak Properties(DOC.US) With Hold Rating, Maintains Target Price $23 - Moomoo
Healthpeak, Brookfield Launch $2.1B Outpatient CRE Venture - Yahoo Finance
Healthpeak Properties' Q2 2026 earnings: What to expect - MSN
Brookfield Asset Management forms joint venture with US REIT Healthpeak Properties - MSN
Brookfield Asset Management Ltd. and its affiliates acquired 49% stake in Portfolio of Outpatient Medical Buildings Across the United States from Healthpeak Properties, Inc. for approximately $1 billion. - marketscreener.com
Brookfield Asset Management forms joint venture with U.S. REIT Healthpeak Properties - BNN Bloomberg
Healthpeak, Brookfield Launch $2.1B Outpatient Medical JV - Connect CRE
Healthpeak Properties and Brookfield Form a $2.1 Billion Strategic Joint Venture - AOL.com
Kirkland, Latham Guide $2.1B Healthpeak, Brookfield JV Deal - Law360
Healthpeak Properties and Brookfield form a $2.1b strategic joint venture - Institutional Real Estate, Inc.
Healthpeak Properties, Brookfield form $2.1b strategic JV - Institutional Real Estate, Inc.
Healthpeak forms $2.1 billion joint venture with Brookfield By Investing.com - Investing.com Nigeria
Healthpeak and Brookfield Form $2.1 Billion Outpatient Medical Real Estate Venture - citybiz
Healthpeak Properties Sells Brookfield Minority Stake in $2.1 Billion Portfolio - marketscreener.com
Healthpeak Properties Partners With Brookfield Asset Management in $2.1 Billion Medical Buildings Venture - marketscreener.com
Healthpeak and Brookfield form $2.1B joint venture (DOC:NYSE) - Seeking Alpha
Healthpeak forms $2.1 billion joint venture with Brookfield - Investing.com India
Healthpeak Properties And Brookfield Form A $2.1 Billion Strategic Joint Venture - TradingView
Brookfield Takes 49% Stake in 86 Outpatient Medical Buildings - Stock Titan
Healthpeak Properties stock hits 52-week high at 22.13 USD By Investing.com - Investing.com South Africa
Healthpeak Properties Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Healthpeak Properties stock hits 52-week high at 22.13 USD - Investing.com
Healthpeak Properties (DOC) Reaffirms Dividend As Fair Value Stays In Focus - Yahoo Finance
What is Janus Living and Why is Healthpeak Spinning it Off - Kavout | AI
US40414LAR0 Bond Profile — Key Metrics - TradingView
US40414LAR0 Bond Coupon Profile — Rate & Payments - TradingView
US40414LAR0 Bond Risk Profile - TradingView
DOC Maintained by Wells Fargo -- Price Target Raised to $22.00 - GuruFocus
Wells Fargo Maintains Healthpeak Properties(DOC.US) With Hold Rating, Raises Target Price to $22 - Moomoo
PEAK4849213 Bond Profile — Key Metrics - TradingView
Healthpeak Properties Inc Stock (DOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):